Business
AstraZeneca vaccine volunteer developed spinal inflammation & ‘rare neurological condition’ after two doses – report – RT
A British participant in AstraZeneca’s coronavirus vaccine trial was diagnosed with a serious neurological disorder weeks after her second dose of the inoculation, an internal company document shows.
A previously healthy 37-year-old woman was hospitalized this month after receiving two injections of the pharmaceutical giant’s new vaccine, where it was determined she developed transverse myelitis, a rare neurological ailment caused by inflammation of the spine, according to an internal AstraZeneca safety report obtained by CNN.
Though the report states the woman, who has not been identified by name, had no adverse reaction after her first dose in early June, she began to experience neurologi…
-
Noosa News24 hours agoWest Coast Eagles draftee Josh Lindsay wants to carry on Troy Selwood’s legacy
-
General10 hours agoGrieving parents of 4yo boy who drowned in Officer suing Melbourne Water, Cardinia council
-
Noosa News20 hours agoYummy Snack Foods pulled from shelves over labelling issue
-
Noosa News5 hours agoSES celebrates 50 years | Noosa Today